Related Experiment Video
Updated: May 5, 2026

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay
Published on: February 9, 2021
Oxadiazoles as privileged motifs for promising anticancer leads: recent advances and future prospects
Imtiaz Khan1, Aliya Ibrar, Naeem Abbas
1Department of Chemistry, Quaid-i-Azam University, Islamabad, Pakistan.
Abstract:
Taking into account the rising trend of the incidence of cancers of various organs, effective therapies are urgently needed to control human malignancies. The rapid emergence of hundreds of new agents that modulate an ever-growing list of cancer-specific molecular targets offers tremendous hope for cancer patients. However, almost all of the chemotherapy drugs currently on the market cause serious side effects. Based on these facts, the design of new chemical entities as anticancer agents requires the simulation of a suitable bioactive pharmacophore. The pharmacophore not only should have the required potency but must also be safer on normal cell lines than on tumor cells. In this perspective, oxadiazole scaffolds with well-defined anticancer activity profile have fueled intense academic and industrial research in recent years. This paper is intended to highlight the recent advances along with current developments as well as future outlooks for the design of novel and efficacious anticancer agents based on oxadiazole motifs.
Insights
Novel anticancer agents are needed due to rising cancer incidence and chemotherapy side effects. Oxadiazole scaffolds show promise for developing potent and safer cancer therapies with improved efficacy.
Area of Science:
- Medicinal Chemistry
- Oncology
- Drug Discovery
Background:
- Rising global cancer incidence necessitates novel therapeutic strategies.
- Current chemotherapy drugs often cause severe side effects, limiting their use.
- Targeted therapies offer hope but require careful design of bioactive pharmacophores.
Purpose of the Study:
- To review recent advances in the design of anticancer agents based on oxadiazole scaffolds.
- To highlight current developments and future perspectives in oxadiazole-based drug discovery.
- To emphasize the importance of designing potent and selective anticancer agents.
Main Methods:
- Literature review of recent research on oxadiazole derivatives as anticancer agents.
- Analysis of structure-activity relationships for oxadiazole-based compounds.
- Discussion of the potential of oxadiazole motifs in developing safer cancer therapies.
Main Results:
- Oxadiazole scaffolds exhibit a well-defined anticancer activity profile.
- Numerous studies demonstrate the efficacy of oxadiazole derivatives against various cancer cell lines.
- The design of oxadiazole-based agents allows for improved potency and selectivity.
Conclusions:
- Oxadiazole motifs are promising scaffolds for the development of novel anticancer drugs.
- Future research should focus on optimizing oxadiazole derivatives for enhanced efficacy and reduced toxicity.
- Oxadiazole-based drug discovery holds significant potential for improving cancer treatment outcomes.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Targeted Cancer Therapies
Drug Discovery: Overview
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Pharmacogenomics: Identification of New Drug Targets
Treatment Resistent Cancers

